Atlas FDA

MYNX VASCULAR CLOSURE DEVICE

FDA premarket approval P040044/S025 · decided 2010-07-09

Approval details

PMA number
P040044
Supplement
S025
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
MYNX VASCULAR CLOSURE DEVICE
Generic name
Device, hemostasis, vascular
Applicant
Cordis US Corporation
Date received
2010-02-12
Decision date
2010-07-09
Days to decision
147 days
Decision code
APPR
Product code
MGB
Advisory committee
Cardiovascular
Expedited review
No
Location
Miami Lakes, FL
Statement
APPROVAL FOR IMPLEMENTATION OF A NEW, SINGLE PROGRAMMABLE CONDITIONING CHAMBER.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.